Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
Authors:
- Bozena DobrzyckaBDBozena Dobrzycka
- Sławomir J TerlikowskiSTSławomir J Terlikowski
- Andrzej MazurekAMAndrzej Mazurek
- Oksana KowalczukOKOksana Kowalczuk
- Wiesława NiklińskaWNWiesława Niklińska
- Lech ChyczewskiLCLech Chyczewski
- Marek KulikowskiMKMarek Kulikowski
Open Access
- 8 May 2009
- journal article
- Published by VM Media Group sp. z o.o in Folia Histochemica et Cytobiologica
- Vol. 47 (1) , 65-68
Abstract
Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.Keywords
This publication has 12 references indexed in Scilit:
- Molecular Carcinogenesis of Endometrial CancerTaiwanese Journal of Obstetrics and Gynecology, 2007
- Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometriumPathology, 2007
- Endometrial cancerThe Lancet, 2005
- Endometrial cancerCell and tissue research, 2005
- Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classificationVirchows Archiv, 2004
- Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysisGynecologic Oncology, 2003
- Immunohistochemical Analysis of MIB-1 Proliferative Activity in Human Endometrial Cancer. Correlation with Clinicopathological Parameters, Patient Outcome, Retinoblastoma Immunoreactivity and K-Ras Codon 12 Point MutationsJournal of Molecular Histology, 2001
- The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancerEuropean Journal of Cancer, 1997
- K-rasPoint Mutations in Endometrial Carcinoma: Effect on Outcome Is Dependent on Age of PatientGynecologic Oncology, 1996
- ras Gene Mutations in Human Endometrial CarcinomaOncology, 1996